Fidelity Investments’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Buy
14,706,843
+8,848
+0.1% +$7.47K ﹤0.01% 2001
2025
Q4
$11.5M Hold
14,697,995
﹤0.01% 1972
2025
Q3
$10.6M Buy
14,697,995
+1,347,330
+10% +$6.11M ﹤0.01% 1976
2025
Q2
$67.7M Buy
13,350,665
+457,136
+4% +$1.8M ﹤0.01% 1276
2025
Q1
$38.9M Buy
12,893,529
+796,100
+7% +$2.9M ﹤0.01% 1448
2024
Q4
$43.8M Buy
12,097,429
+728,000
+6% +$2.2M ﹤0.01% 1432
2024
Q3
$20M Buy
11,369,429
+1,017,788
+10% +$1.85M ﹤0.01% 1704
2024
Q2
$16.1M Buy
10,351,641
+1,428,431
+16% +$2.49M ﹤0.01% 1719
2024
Q1
$17.4M Buy
8,923,210
+139,201
+2% +$243K ﹤0.01% 1704
2023
Q4
$12.4M Buy
8,784,009
+227,084
+3% +$291K ﹤0.01% 1782
2023
Q3
$13.5M Buy
8,556,925
+413,162
+5% +$765K ﹤0.01% 1734
2023
Q2
$17.6M Buy
8,143,763
+169,456
+2% +$370K ﹤0.01% 1694
2023
Q1
$16.7M Buy
7,974,307
+3,622,900
+83% +$7.94M ﹤0.01% 1685
2022
Q4
$9.53M Buy
4,351,407
+57,651
+1% +$136K ﹤0.01% 1911
2022
Q3
$12.9M Buy
4,293,756
+85,319
+2% +$286K ﹤0.01% 1792
2022
Q2
$11.9M Buy
4,208,437
+39,068
+0.9% +$141K ﹤0.01% 1880
2022
Q1
$22.3M Buy
4,169,369
+768
+0% +$4.35K ﹤0.01% 1732
2021
Q4
$31.1M Buy
4,168,601
+105,308
+3% +$879K ﹤0.01% 1617
2021
Q3
$36.9M Buy
4,063,293
+2,387,413
+142% +$14.3M ﹤0.01% 1553
2021
Q2
$8.18M Buy
1,675,880
+91,196
+6% +$389K ﹤0.01% 2186
2021
Q1
$7.05M Buy
1,584,684
+56,866
+4% +$267K ﹤0.01% 2156
2020
Q4
$5.93M Buy
1,527,818
+124,944
+9% +$457K ﹤0.01% 2137
2020
Q3
$4.53M Hold
1,402,874
﹤0.01% 2099
2020
Q2
$6.23M Hold
1,402,874
﹤0.01% 1978
2020
Q1
$3.93M Buy
1,402,874
+911,425
+185% +$3.93M ﹤0.01% 2006
2019
Q4
$2.05M Hold
491,449
﹤0.01% 2244
2019
Q3
$1.72M Buy
491,449
+2
+0% +$7 ﹤0.01% 2305
2019
Q2
$2.52M Buy
491,447
+182,272
+59% +$1.24M ﹤0.01% 2269
2019
Q1
$2.38M Hold
309,175
﹤0.01% 2254
2018
Q4
$2.15M Hold
309,175
﹤0.01% 2262
2018
Q3
$3.52M Sell
309,175
-10,419
-3% -$114K ﹤0.01% 2251
2018
Q2
$4.07M Sell
319,594
-540
-0.2% -$12.8K ﹤0.01% 2195
2018
Q1
$11.9M Buy
320,134
+1,295
+0.4% +$60.7K ﹤0.01% 1915
2017
Q4
$15.6M Buy
318,839
+38,044
+14% +$2.34M ﹤0.01% 1808
2017
Q3
$19.9M Buy
280,795
+26,668
+10% +$1.24M ﹤0.01% 1700
2017
Q2
$12.3M Hold
254,127
﹤0.01% 1873
2017
Q1
$12.5M Hold
254,127
﹤0.01% 1885
2016
Q4
$7.65M Hold
254,127
﹤0.01% 2058
2016
Q3
$11.3M Buy
254,127
+9
+0% +$389 ﹤0.01% 1935
2016
Q2
$9.89M Buy
254,118
+433
+0.2% +$20.1K ﹤0.01% 1976
2016
Q1
$14M Buy
253,685
+309
+0.1% +$23.5K ﹤0.01% 1822
2015
Q4
$34.9M Buy
253,376
+98
+0% +$13.9K ﹤0.01% 1411
2015
Q3
$36.4M Buy
253,278
+51
+0% +$11.6K 0.01% 1386
2015
Q2
$65.7M Buy
+253,227
New +$78.6M 0.01% 1217

Other funds holding ATYR